INTRODUCTION
============

Chromosomes in multicellular eukaryotes are organized into a series of discrete, topologically independent domains (TADs) ([@R1]). Within these domains, dynamic interactions can be observed between regulatory elements (enhancers and silencers) and the promoters for their gene targets ([@R2]). In contrast, regulatory interactions between enhancers/silencers located in one TAD and potential gene targets in neighboring TADs are greatly suppressed. Special elements, called chromatin boundaries or insulators, are thought to be responsible for restricting regulatory interactions to enhancers/silencers and genes that reside within the same TAD ([@R3]).

In mammals and other vertebrates, a single protein, CTCF, has been implicated in boundary function ([@R3]). CTCF is a highly conserved, polydactyl, C2H2 zinc finger DNA binding protein. It contains 11 C2H2 zinc fingers and binds to a recognition sequence of 15 base pairs (bp). The CTCF protein localizes to the insulators that define many of the TAD boundaries in vertebrates, and genome-wide studies have shown that TAD endpoints are frequently correlated with the presence of two convergently oriented CTCF recognition sequences ([@R4]--[@R6]). In murine embryonic stem cells, for example, more than 60% of the CTCF-delimited TADs have convergently oriented CTCF sites at their borders ([@R6]). TAD formation is thought to involve a loop extrusion mechanism ([@R7]). In this mechanism, a cohesin complex encircles the end of a small loop protrusion and then proceeds along the chromatin fiber, extruding a chromatin loop until the cohesin complex encounters CTCF proteins bound to their convergent recognition sequences. This assembly generates a looped domain that insulates the regulatory elements and genes located within the CTCF-cohesin-CTCF--delimited loop from the actions of regulatory elements and genes on either side of the loop. This model makes several predictions regarding the properties of the CTCF-dependent insulators that define the boundaries of TADs. The first prediction is that CTCF-binding sites are necessary for insulator activity. The second prediction is that the CTCF-binding sites are sufficient for insulator activity. To satisfy the criteria of sufficiency, the CTCF protein must share properties with the so-called "pioneer" class of DNA binding proteins, including the ability to access its cognate binding sites within chromatin, without the assistance of accessory DNA binding proteins. Moreover, it must remain stably bound not only during TAD formation but also as long as the CTCF-cohesin-CTCF loop persists. In addition to this pioneer activity, the presence of a single CTCF protein should be sufficient to generate a fully functional insulator that is capable of blocking regulatory element/gene interactions on either side of the bound protein.

In the studies reported here, we used a boundary replacement strategy in the *Drosophila bithorax* complex (BX-C) to test whether these predictions are true for the fly dCTCF protein and for two other members of the polydactyl C2H2 zinc finger DNA binding protein family, Pita and Su(Hw). Similar to the vertebrate Hox clusters, the fly dCTCF protein localizes to boundaries in the BX-C ([@R8]). These insulators play a central role in determining the chromosomal architecture and regulatory activities of the parasegment-specific regulatory domains that control the expression of the three BX-C homeotic genes, *Ultrabithorax* (*Ubx*), *abdominal-A* (*abd-A*), and *Abdominal-B* (*Abd-B*) ([@R9]). In addition, as in vertebrates, dCTCF is one of dozens of polydactyl C2H2 zinc finger proteins encoded in the fly genome ([@R10], [@R11]). However, unlike vertebrates, several of these polydactyl C2H2 zinc finger protein family members \[Su(Hw), Pita, Zipic, Zw5, CLAMP, and Opbp\] have been shown to play roles in chromosomal architecture in flies, and it is likely that other members of this large protein family will have similar functions ([@R12]--[@R17]). Moreover, like dCTCF, two of these zinc finger proteins, Su(Hw) and Pita, are components of boundaries in BX-C and are important in the proper regulation of the BX-C homeotic genes ([@R18]--[@R20]).

The 300-kb BX-C is subdivided into a series of functionally autonomous regulatory domains ([@R9]). As shown in [Fig. 1](#F1){ref-type="fig"}, two of these domains, *abx/bx* and *bxd/pbx*, are responsible for regulating the expression of *Ubx* in parasegments PS5 (segment T3) and PS6 (segment A1). The *infra-abdominal* (*iab*) domains regulate the transcription of *abd-A* and *Abd-B*. The *abd-A* gene is controlled by *iab-2*, *iab-3*, and *iab-4* in parasegments PS7 (A2), PS8 (A3), and PS9 (A4), respectively. Four domains, *iab-5*, *iab-6*, *iab-7*, and *iab-8*, regulate *Abd-B* expression in PS10 (A5), PS11 (A6), PS12 (A7), and PS13 (A8), respectively. These parasegment-specific regulatory domains are activated sequentially in successive parasegments along the anterior-posterior axis. For example, *iab-6* is turned on in PS11, where it specifies PS11 identity by controlling *Abd-B* expression in an appropriate parasegment-specific pattern. The adjacent regulatory domain, *iab-7*, is silenced in PS11 by a Polycomb-dependent mechanism, as is *iab-8*. In PS12, *iab-7*, but not *iab-8*, is activated, and it controls *Abd-B* expression in this parasegment. A similar sequential pattern of activation can be found elsewhere in the complex. In PS6, for example, the *bxd/pbx* regulatory domain is activated and controls *Ubx* expression, while the adjacent regulatory domain, *iab-2*, is silenced. In PS7, *iab-2* is activated and regulates *abd-A* expression, instead of *Ubx* expression.

![Fragments of *Fub* (*Fab-2*), *Mcp*, and *Fab-8* that were used for replacements.\
The organization of the genes and regulatory domains in BX-C is shown on the left. Orange, blue, and green arrows represent transcripts of *Ubx*, *abd-A*, and *Abd-B* genes, respectively. *Abx/bx*, *bxd/pbx*, and *iab-2*--*iab-8* are responsible for the regulation of these three genes and for the development of the 5 to 13 parasegments (PS)/segments (T3-A8). The lines with colored circles mark characterized (*Fub*, *Mcp*, *Fab-6*, *Fab-7*, and *Fab-8*) and predicted (*Fab*, *Fab-1*, *Fab-3*, and *Fab-4*) boundaries. dCTCF-, Pita-, and Su(Hw)-binding sites at the boundaries are shown as red, blue, and green circles/ovals, respectively. On the right side of the figure, molecular maps of the *Fub* (*Fab-2*), *Mcp*, *Fab-7*, and *Fab-8* boundaries are shown, including their deletions and the fragments used in the replacement experiments. Deoxyribonuclease I hypersensitive sites are shown as light gray boxes above the coordinate bar. The proximal and distal deficiency endpoints of the *Fab-2* and *Fab-7* deletions used in the replacement experiments are indicated by breaks in the black line. The *attP*, *lox*, and *frt* sites used in genome manipulations are shown as white, gray, and black triangles, respectively. On the right side, summarizing data for insulator activity with the various fragments in the *F2^attP^* and *Fab-7^attP50^* insertion sites are shown in embryos and adults. Signs +, ±, and − indicate complete, moderate, and lack of the insulator activity, respectively. ND, not determined.](aaz3152-F1){#F1}

To generate the appropriate parasegment-specific patterns of *Hox* gene expression, the nine regulatory domains must be able to function autonomously. Autonomy is conferred by the boundary elements ([Fig. 1](#F1){ref-type="fig"}) that bracket each parasegment-specific regulatory domain ([@R9], [@R18], [@R21]--[@R26]). Like boundary elements elsewhere in the fly genome, all known BX-C boundaries contain sites for one or several architectural proteins, such as dCTCF, Su(Hw), and Pita ([@R8], [@R12], [@R20], [@R22]). The most thoroughly characterized *BX-C* boundaries are *Fab-7* and *Fab-8*, which bracket the *iab-7* regulatory domain ([@R9], [@R21], [@R25]--[@R27]). Deletion of *Fab-7* fuses the *iab-6* and *iab-7* regulatory domains, enabling parasegment-specific initiation elements in *iab-6* to ectopically activate *iab-7* ([@R25], [@R27]). As a consequence, *iab-7* drives *Abd-B* expression in PS11 (and PS12), transforming PS11 (A6) into a copy of PS12 (A7). An equivalent gain-of-function (GOF) transformation of PS12 (A7) into PS13 (A8) is observed when *Fab-8* is deleted. Functional studies indicate that *Fab-7* and *Fab-8* have two distinct activities. The first activity is blocking cross-talk, and it is this activity that is needed to ensure that adjacent regulatory domains can function autonomously. The second activity is a bypass function. The bypass function is needed so that regulatory domains distal to one or more of the *Abd-B* boundaries (e.g., *iab-6* and *Fab-7/Fab-8*) can "jump over" the intervening boundaries and contact the *Abd-B* promoter ([@R28]). In the case of *Fab-8*, blocking activity depends on two dCTCF-binding sites, whereas bypass activity requires recognition sequences for a large multiprotein complex, called the large boundary complex (LBC) ([@R19]). Similar to the deletions of *Fab-7* and *Fab-8*, deletions of *Fab-6* (which separates *iab-5* and *iab-6*), *Mcp* (which separates *iab-4* and *iab-5*), and *Fub* (which separates *bxd/pbx* and *iab-2*) result in GOF transformations in the parasegment (segment) specified by the centromere proximal regulatory domain ([@R22], [@R24], [@R25]). *Mcp* and *Fub* differ from *Fab-6*, *Fab-7*, and *Fab-8* because they correspond to the border between the sets of regulatory domains that control different BX-C genes. *Mcp* separates the regulatory domains for *abd-A* and *Abd-B*, whereas *Fub* separates the regulatory domains controlling *Ubx* and *abd-A* ([Fig. 1](#F1){ref-type="fig"}). Because of their roles in demarking the limits of the regulatory domains that control *abd-A* versus *Abd-B* and *Ubx* versus *abd-A*, *Mcp* and *Fub* require blocking but not bypass activity.

To address the questions of necessity and sufficiency, we used two BX-C boundary replacement platforms, *Fab-7* ([@R27]) and *Fub*. In both platforms, the endogenous BX-C boundary was deleted, and an *attP* site was introduced in its place. This *attP* site can then be used to insert any sequences of interest to test for insulator functions. For both of these BX-C chromatin neighborhoods, we find that single binding sites for polydactyl zinc finger DNA binding proteins are insufficient for the cognate protein to access its binding site and/or to reconstitute a functional insulator. Instead, other sequences, recognized by known or unknown factors, are required to generate boundary activity.

RESULTS
=======

The two dCTCF sites in the *Fab-8* boundary are insufficient for blocking activity
----------------------------------------------------------------------------------

The *Fab-8* boundary is included in an approximately 400-bp nuclease hypersensitive region and contains two divergently oriented dCTCF sites that are separated by 29 bp ([@R8], [@R21]). In previous boundary replacement experiments, we found that a 337-bp fragment, which spans most of the *Fab-8* nuclease hypersensitive site (*F8^337^*), was sufficient to fully rescue a *Fab-7* boundary deletion, *Fab-7^attP50^* ([@R18]). While males carrying the starting *Fab-7^attP50^* deletion lack both A6 and A7 ([Fig. 2A](#F2){ref-type="fig"}), males carrying the *F8^337^* replacement have an A6 segment that has a morphology identical to wild-type (*wt*) males. This result indicates that *F8^337^* has both blocking and bypass functions and can fully substitute for the endogenous *Fab-7* boundary. We also found that the two dCTCF-binding sites in *Fab-8* are essential for boundary function in the replacement experiments, and male flies carrying a *Fab-8* boundary with mutated dCTCF sites lack the A6 segment, just like starting *Fab-7^attP50^* deletion platform ([@R18]).

![The number of dCTCF sites is critical for boundary function.\
(**A**) Top: Schematic presentation of *Fab-7* substitution. *CTCF^×4^* and *CTCF^×3^* represent multimerized proximal CTCF sites from *Fab-8.* All designations are the same as described in [Fig. 1](#F1){ref-type="fig"}. Bottom: Morphology of the male abdominal segments (numbered) in *F8^209^*, *F8^106^*, *F8^106^ + HS3*, *CTCF^×4^*, *CTCF^×3^*, and *CTCF^×3^ + HS3*. The filled red arrowheads show morphological features indicative of GOF transformations. The empty red arrowheads show the signs of the LOF transformation, which is directly correlated with the boundary functions of tested DNA fragments. wt, wild type. (**B**) Binding of dCTCF and CP190 with *F8^209^*, *F8^106^*, and *F8^106^ + HS3*. (**C**) Binding of dCTCF and CP190 with *CTCF^×4^*, *CTCF^×3^*, and *CTCF^×3^ + HS3*. The results of ChIPs are presented as a percentage of the input DNA and normalized against a positive genomic site, the *59F5* region, for dCTCF and CP190 binding. The negative control is the *rpl32* promoter region. Error bars indicate SDs of quadruplicate polymerase chain reaction (PCR) measurements from two independent biological samples of chromatin. Asterisks indicate significance levels: \**P* \< 0.05 and \*\**P* \< 0.01.](aaz3152-F2){#F2}

Although these findings demonstrate the necessity of the dCTCF sites, they do not address the question of sufficiency. To test for sufficiency, we started with a previously characterized *Fab-8* derivative, *F8^209^*, in which 128 bp from the proximal side of *F8^337^* was deleted ([Fig. 1](#F1){ref-type="fig"}). This deletion removes the recognition sequence for the LBC but retains the two dCTCF-binding sites. As previously reported ([@R19]), *F8^209^* blocks cross-talk between *iab-6* and *iab-7*, similar to *F8^337^*; however, it does not support bypass ([Fig. 2A](#F2){ref-type="fig"}). Unlike the starting *Fab-7^attP50^* platform, an A6-like segment is present in *F8^209^* males, indicating that this truncated boundary is able to prevent cross-talk between *iab-5* and *iab-6*. However, the identity of this "A6-like" segment is A5, not A6. Thus, instead of the banana-shaped A6 sternite observed in wild-type flies, the A6 sternite in *F8^209^* flies has a quadrilateral shape and is covered in bristles just like the A5 sternite. A similar loss-of-function (LOF) A6→A5 transformation is evident in the A6 tergite, which is covered in trichomes like A5 tergite (fig. S1). To further define the sequences needed for blocking, we deleted a 103-bp sequence from the distal side of *F8^209^*, leaving the two dCTCF sites (plus their immediate flanking sequences: 26 bp on the proximal side and 10 bp on the distal side). In contrast to *F8^209^* males, the A6 segment is almost completely absent in *F8^106^* males ([Figs. 1](#F1){ref-type="fig"} and [2A](#F2){ref-type="fig"}). This nearly complete A6→A7 transformation indicates that the two *Fab-8* dCTCF sites are not sufficient to effectively block cross-talk between *iab-6* and *iab-7.*

dCTCF association in vivo is compromised by *F8^106^*
-----------------------------------------------------

In vivo, the *Fab-8* boundary is marked by an approximately 400-bp nucleosome-free region ([@R21]). Thus, one plausible reason why the *F8^106^* element does not have blocking activity is that additional sequences/factors are necessary to facilitate dCTCF binding to chromatin. To test this idea, we used chromatin immunoprecipitation (ChIP) with material from 3-day adult males to examine the in vivo association of dCTCF association with *F8^106^* and *F8^209^*. [Figure 2B](#F2){ref-type="fig"} shows that dCTCF binding to *F8^106^* in vivo is reduced nearly sixfold compared with dCTCF binding with *F8^209^*. In accordance with the role played by dCTCF in the recruitment of the architectural protein CP190 to chromatin, we also observe a reduction in CP190 association with *F8^106^* compared to *F8^209^*. These results suggest that additional proteins associated with the distal portion of the *F8^209^* element contribute to dCTCF association and/or boundary activity.

Three dCTCF sites are not sufficient to generate blocking activity
------------------------------------------------------------------

Although the two dCTCF sites in *Fab-8* alone are not sufficient to block cross-talk between *iab-6* and *iab-7*, we found that a multimer containing four dCTCF (CTCF^×4^) sites displayed near-complete blocking activity ([@R19]). To determine the minimal number of dCTCF sites necessary to block cross-talk between *iab-6* and *iab-7* activity, we generated a *CTCF^×3^* replacement ([Fig. 2A](#F2){ref-type="fig"}). *CTCF^×3^* males have a GOF phenotype just like the *Fab-7^attP50^* platform, indicating that three dCTCF sites are not sufficient to provide insulating activity. The loss of insulating activity is probably due, at least in part, to a failure to access the dCTCF-binding sites as ChIP experiments show that dCTCF association with *CTCF^×3^* is reduced approximately twofold compared with *CTCF^×4^* ([Fig. 2B](#F2){ref-type="fig"}). In contrast, the binding of CP190 did not change significantly between *CTCF^×3^* and *CTCF^×4^*.

*Fab-7* HS3 can rescue defective CTCF insulators
------------------------------------------------

The *Fab-7* boundary spans four chromatin-specific nuclease hypersensitive regions: HS\*, HS1, HS2, and HS3 ([@R26]). There are two LBC recognition sequences in *Fab-7* ([@R16]). One corresponds to an \~200-bp sequence, dHS1, on the centromere distal side of the 400-bp hypersensitive region HS1, while the other spans the 200-bp HS3 sequence. Alone, each of these LBC recognition sequences has limited blocking activity; however, when they are combined (*dHS1 + HS3*), they are sufficient to reconstitute a fully functional *Fab-7* boundary ([@R16], [@R29]). Transgene assays ([@R26]) showed that, in addition to its boundary function, HS3 is also a Polycomb response element (PRE). The Polycomb-silencing activity of HS3 depends on several GAGAG motifs and binding sites for the Polycomb protein Pleiohomeotic (Pho) ([@R30]). In contrast, the boundary function of HS3, in combination with dHS1, requires the GAGAG motifs but not the Pho sites ([@R16]). Consistent with these observations, LBC binding in nuclear extracts is largely eliminated by mutations in the GAGAG motifs, whereas mutations in the Pho sites have no effects on LBC binding.

Because the *dHS1 + HS3* combination has full boundary functionality, we wondered whether HS3 would also be able to complement the boundary defects of *F8^106^* and *CTCF^×3^*. Much like *F8^106^*, *HS3* alone has only limited boundary activity: The A6 tergite is greatly reduced in size, while the sternite is missing altogether ([Fig. 2A](#F2){ref-type="fig"}). In contrast, the *F8^106^+ HS3* combination has significant boundary function. In *F8^106^+ HS3* males, the A6 tergite is similar in size to that of wild-type males, indicating that the GOF transformations observed for A6 (PS11) in either *F8^106^* or *HS3* males are almost completely suppressed in the dorsal cuticle. However, the tergite is covered in trichomes (fig. S1). This phenotype indicates that the A6 tergite is transformed into A5 (PS10), which would be expected if the *F8^106^+ HS3* combination does not support bypass. Blocking activity appears to be somewhat weaker in the ventral sternite as this cuticular structure is significantly reduced in size, as expected for a GOF transformation. On the other hand, the residual tissue is covered in bristles, consistent with an LOF transformation caused by a lack of bypass activity. *HS3* also rescued the blocking defects of *CTCF^×3^*, with the morphologies of both the tergite and the sternite, indicating that A6 (PS11) is transformed into A5 (PS10).

Although *HS3* rescued the insulating activity of both *F8^106^* and *CTCF^×3^*, it did not enhance dCTCF binding ([Fig. 2B](#F2){ref-type="fig"}). ChIP experiments show that the dCTCF association with *F8^106^* and *CTCF^×3^* when they are combined with *HS3* is essentially indistinguishable from that observed with each element alone. The same is true for CP190. Note that little or no dCTCF and no CP190 binding are observed for *HS3* either alone or in combination with *F8^106^* or *CTCF^×3^*.

The *Mcp* Pita and dCTCF sites are necessary, but not sufficient, for boundary function
---------------------------------------------------------------------------------------

We next turned our attention to the *Mcp* boundary, which separates the regulatory domains controlling *abd-A* and *Abd-B* expression and has closely spaced (9 bp) binding sites for dCTCF and Pita ([@R25]). In previous replacement experiments, we showed that a 340-bp sequence, *M^340^*, in combination with *HS3*, blocks cross-talk between *iab-6* and *iab-7* when inserted into the *Fab-7^attP50^* replacement platform ([@R20]). Blocking activity in this assay was disrupted by mutations in either the dCTCF- or Pita-binding sites. To test whether these two binding sites are sufficient for boundary function, we generated two truncated replacements, *M^210^* and *M^65^*, which include the *Mcp* dCTCF and Pita sites. We also tested *M^340^* without *HS3*.

Unlike the *M^340^ + HS3* combination, *M^340^* alone has a weak GOF phenotype, indicating that it is unable to completely block regulatory interactions between *iab-6* and *iab-7* ([Fig. 3A](#F3){ref-type="fig"}). In transgene assays, the smaller *M^210^* sequence functioned much like the larger *M^340^* sequence; it had enhancer blocking activity and was able to support long-distance boundary:boundary interactions ([@R31]). However, as a *Fab-7* replacement, the boundary activity of the *M^210^* sequence is less than that of *M^340^* and is also tissue specific. [Figure 3A](#F3){ref-type="fig"} shows that the sternite is completely absent in *M^210^* males, indicating that *M^210^* lacks boundary functions in the PS11 cells that give rise to the ventral A6 cuticle. In contrast, *M^210^* is able to block cross-talk between *iab-6* and *iab-7* in the PS11 cells that form the dorsal A6 tergite; however, the tergite is smaller than normal, indicating that blocking activity is insufficient to prevent *iab-6* initiation elements from activating *iab-7* in a subset of PS11 cells. The smaller *M^65^* replacement has no apparent blocking activity, and males carrying this replacement exhibit a complete GOF transformation of A6 into A7. We also tested whether the boundary defects of *M^210^* and *M^65^* could be rescued when combined with *HS3*. In both cases, blocking activity was largely, if not completely, reconstituted. [Figure 3A](#F3){ref-type="fig"} and fig. S2 show that A6 is transformed into a copy of A5, as would be expected for boundary elements that are able to block cross-talk but fail to mediate bypass.

![Testing boundary activities of *Mcp* sequences.\
(**A**) Top: Schematic presentation of *Fab-7* substitution. Bottom: Morphology of the male abdominal segments (numbered) in *M^340^*, *M^210^*, *M^210^ + PRE M^65^*, and *M^65^ + PRE.* Other designations are the same as those in [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}. (**B**) Binding of dCTCF, Pita, and CP190 with *M^210^*, *M^210^ + PRE M^65^*, and *M^65^ + PRE*. The results of ChIPs are presented as percentages of the input DNA normalized against a positive genomic site: *100C*, for Pita binding; and the *59F5* region, for dCTCF and CP190 binding. The negative control is the *rpl32* promoter region. Error bars indicate SDs of quadruplicate PCR measurements from two independent biological samples of chromatin. Asterisks indicate significance levels: \**P* \< 0.05 and \*\**P* \< 0.01. Other designations are the same as in [Fig. 2](#F2){ref-type="fig"}.](aaz3152-F3){#F3}

We used ChIP with material from 3-day adult males to examine Pita, dCTCF, and CP190 interactions with *M^340^* and *M^65^*. Reducing the length of the *Mcp* sequence had no apparent effect on the Pita association in vivo. In contrast, dCTCF and CP190 binding to *M^65^* were more than twofold less than their binding with *M^340^*. The addition of HS3 restored dCTCF binding, whereas it had no effects on CP190 association ([Fig. 3B](#F3){ref-type="fig"}). Together, these results suggest that unknown proteins associated with the larger *M^340^* and *M^210^* sequences assist in recruiting dCTCF (and CP190) and probably also contribute to boundary activity.

Insulator function of the *Fub* boundary requires the Su(Hw) site, but not the dCTCF site
-----------------------------------------------------------------------------------------

The *Fub* (*Front--ultra-abdominal*) boundary is located between the bithoraxoid (*bxd*) domain, which activates the *Ubx* gene in PS6 (A1), and the *iab-2* domain, which controls *abd-A* expression in PS7 (A2). Bender and Lucas ([@R22]) isolated a 4328-bp *Fub* deletion that resulted in the ectopic activation of *abd-A* in PS6 (A1). Within this large deletion (which included a *jockey* transposable element), there is an approximately 1.3-kb nuclease hypersensitive region, HS*^Fub^*. HS*^Fub^* contains binding sites for Pita, Su(Hw), and dCTCF, and in ChIP experiments, prominent peaks for these zinc finger proteins are observed ([Fig. 1](#F1){ref-type="fig"}) ([@R8], [@R20], [@R32]).

In the first experiment, we used the *Fab-7^attP50^* replacement platform to test the blocking activity of a 177-bp sequence, *F2^177^*, spanning the *Fub*, Su(Hw), and dCTCF sites. [Figure 4](#F4){ref-type="fig"} and fig. S3 show that the A5 segment is duplicated in *F2^177^* male flies, indicating that *F2^177^* is able to block cross-talk between *iab-6* and *iab-7* (but does not support bypass). To assess the contributions of dCTCF and Su(Hw) to boundary function, we generated *F2^177^* mutant variants by deleting either the Su(Hw) (*F2*^*177*Δ*Su*^)-- or the dCTCF (*F2^177ΔC^*)--binding sites ([Fig. 4A](#F4){ref-type="fig"} and fig. S3). Using electrophoretic mobility shift assays, we found that the Su(Hw) protein shifts a wild-type *F2^177^* DNA probe but not the mutant *F2*^*177*Δ*Su*^ probe (fig. S4). Similarly, *F2^177^* is shifted by the dCTCF protein, whereas the *F2*^*177*Δ*C*^ mutant is not. These two mutations had very different effects on the insulating activity of the *F2^177^* element. The deletion of the Su(Hw)-binding site completely disrupts its insulating activity. [Figure 4](#F4){ref-type="fig"} shows that A6 is absent, indicating that cells in PS11 have assumed a PS12 identity. By contrast, the dCTCF deletion has no apparent effects on boundary function, and like the wild-type *F2^177^* boundary, A6 is transformed into a copy of A5 in the presence of *F2*^*177*Δ*C*^. Thus, Su(Hw), but not dCTCF, is critical for the insulating activity of *Fub^177^*.

![Testing the role of dCTCF and Su(Hw) in boundary activity of *F2^177^*.\
(**A**) Top: Schematic presentation of *Fab-7* substitution. Bottom: Morphology of the abdominal segments (numbered) in *F2^177^*, *F2*^*177*Δ*C*^, *F2^177Δ41^*, *F2^177ΔSu^*, and *F2^95^* flies. Other designations are the same as those in [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}. (**B**) Binding of dCTCF, Pita, and CP190 with *F2^177^*, *F2*^*177*Δ*C*^, and *F2*^*177*Δ*Su*^. The results of ChIPs are presented as the percentage of input DNA, normalized against a positive genomic site: *62D*, for Su(Hw) binding; and the *59F5* region, for dCTCF and CP190 binding. The negative control is the *rpl32* promoter region. Error bars indicate SDs of quadruplicate PCR measurements from two independent biological samples of chromatin. Asterisks indicate significance levels: \**P* \< 0.05 and \*\**P* \< 0.01. Other designations are the same as in [Fig. 2](#F2){ref-type="fig"}.](aaz3152-F4){#F4}

We used ChIP experiments to compare Su(Hw) and dCTCF binding with the wild-type and mutant versions of *F2^177^* ([Fig. 4B](#F4){ref-type="fig"}). In *F2*^*177*Δ*C*^ males, dCTCF binding was not detected, whereas no changes were observed for Su(Hw) binding. In contrast, the deletion of the Su(Hw) site in *F2*^*177*Δ*Su*^ males not only results in the complete loss of Su(Hw) binding but also strongly reduces dCTCF enrichment. These findings suggest that Su(Hw) binding is required for the efficient recruitment of dCTCF to *F2^177^*. The binding of CP190 was only moderately reduced in *F2*^*177*Δ*Su*^ males, suggesting that additional, unknown proteins that bind to *F2^177^* recruit CP190.

We generated two additional *F2^177^* mutants, one in which we deleted an internal 41-bp sequence that includes the dCTCF-binding site and one in which we deleted an 82-bp sequence (including the dCTCF site) from the centromere distal side of the *F2^177^* element. The 41-bp deletion mutant, *F2^177Δ41^*, displayed full boundary activity, and the A6 segment resembled A5 ([Fig. 4A](#F4){ref-type="fig"}). In contrast, the insulating activity of the 82-bp deletion, *F2^95^*, was substantially compromised. The A6 sternite was absent, and only a residual A6 tergite was observed. Thus, like the other BX-C boundaries that we have tested using the *Fab-7^attP50^* replacement platform, the presence of a single binding site for a polydactyl zinc finger DNA binding protein, Su(Hw), is not sufficient for boundary function.

*F2^177^* blocks cross-talk in its endogenous location
------------------------------------------------------

When introduced into a heterologous context between *iab-6* and *iab-7*, *F2^177^* blocks cross-talk between these two *Abd-B* regulatory domains. This finding raises the question of whether *F2^177^* would fulfill the same function in its native context, between the *bxd* and *iab-2* regulatory domains ([Fig. 1](#F1){ref-type="fig"}). To address this question, we used the CRISPR-Cas9 system to delete a 2106-bp DNA segment (183,576 to 185,681 in SEQ89E numbering) that spans the *Fub* nuclease hypersensitive site ([@R32]), and in its place, we introduced a *3×P3-DsRed* reporter, flanked by *lox* sites and containing an *attP* site (*F2^attP^*; fig. S5).

Flies heterozygous or homozygous for the *F2^attP^* deletion showed evidence of a GOF transformation from a PS6 to a PS7 identity. In wild-type flies, the A1 (PS6) tergite has a distinct shape (pinched along the anterior margin) and is covered in thin, short hairs. On the ventral side, the A1 sternite is absent ([Fig. 5](#F5){ref-type="fig"}). In hetero- or homozygous *F2^attP^* flies, the A1 (PS6) segment is transformed toward A2 (PS7). The anterior margin of the tergite is wider than that in wild-type flies, while the posterior margin is pigmented as is the case in A2. Also similar to A2, the A1 tergite is covered in large bristles instead of fine hairs. The ventral cuticle also differs from wild type in that a sternite is present. It is covered in bristles and resembles the sternite in A2. In addition, all *F2^attP^* homozygous flies have crumpled or unfolded wings ([Fig. 5B](#F5){ref-type="fig"}). *F2^attP^* homozygotes also display additional phenotypes, including low viability and sterility. Approximately 30% of homozygotes have extra tissues along the upper margin of A1 ([Fig. 5](#F5){ref-type="fig"}) and lack one or both halters and/or third legs. The *F2^attP^* chromosome is also lethal in combination with the TM6 balancer (which carries a *Ubx* mutation). The transformations observed in the adult cuticle are reflected in the pattern of *abd-A* expression in the embryo. In wild-type embryos, *abd-A* is off in PS5 and PS6, whereas it is active in PS7 (A2) and in the more posterior parasegments PS8--PS12 ([Fig. 6](#F6){ref-type="fig"}). In *F2^attP^* embryos, we detect Abd-A protein expression in PS6.

![Testing the activity of dCTCF and Su(Hw) in *F2^177^*, when inserted in place of the *Fub* boundary.\
(**Top**) Schematic presentation of the *Ubx* and *abd-A* regulatory regions with *F2^attP^* platform. (**Bottom**) Morphology of the abdominal segments of different *Fub* replacements. The red arrows show the signs of the GOF phenotype: the appearance of A1 sternite and the appearance of bristles on the A1 tergite. Asterisks at the arrow show that this sign is not full penetrance. The additional tissues in *F2^attP^* and the split of A1 tergite in *F2*^Δ*41*^ are present in approximately 30% of homozygous flies. The several additional bristles on A1 tergite of *F2*^Δ*41*^ are present in approximately 80% of homozygous flies. Wing phenotypes in Fub mutants are shown under cuticle images. "\<10%" means that about 10% of the flies do not have fully spread wings, while the remaining 90% are of the wild type. "100%" designates that all homozygous flies have wing phenotypes, but the wings can be both slightly spread and completely crumpled. Other designations are the same as in [Fig. 2](#F2){ref-type="fig"}.](aaz3152-F5){#F5}

![Expression of the *abd-A* gene in embryos with different *F2^attP^* replacements.\
Each panel shows a confocal image of the embryo at stage 14, stained with Abd-A (yellow). Parasegments are numbered from 5 to 12, on the right side of each embryo image. Red arrowheads indicate the ectopic expression of Abd-A.](aaz3152-F6){#F6}

We used the *attP* site in the *F2^attP^* deletion to test the boundary function of *F2^177^* and several of its mutant derivatives. We found that *F2^177^* rescues the lethality and sterility associated with the much larger *F2^attP^* deletion, and as shown in [Fig. 6](#F6){ref-type="fig"}, the morphology of A1 resembles that of wild-type flies. Similarly, unlike *F2^attP^*, Abd-A expression is absent in PS6 ([Fig. 6](#F6){ref-type="fig"}). Curiously, a small fraction (\<10%) of homozygous *F2^177^* flies display a weak, crumpled wing phenotype. With the exception of this anomaly, these observations suggest that the small *F2^177^* fragment is able to effectively block cross-talk between the *bxd* and *iab-2* regulatory domains.

The Su(Hw)-binding site in *F2^177^* appears to be critical for blocking activity, as *F2*^*177*Δ*Su*^ flies display a strong transformation of A1 into A2 ([Fig. 5](#F5){ref-type="fig"}). Like *F2^attP^*, the A1 tergite in *F2*^*177*Δ*Su*^ flies is covered in bristles, and there is a ventral sternite whose morphology resembles the A2 sternite. However, unlike homozygous *F2^attP^* flies, homozygous *F2*^*177*Δ*Su*^ flies display near-normal viability and usually have a wild-type wing phenotype. Unexpectedly, Abd-A expression in *F2*^*177*Δ*Su*^ embryos resembles that of wild-type embryos ([Fig. 6](#F6){ref-type="fig"}), raising the possibility that the blocking activity of the Su(Hw)-binding site mutant is tissue and/or stage specific. The phenotype of the larger dCTCF deletion (*F2*^*177*Δ*41*^) suggests that it retains significant insulating activity. Similar to wild-type flies, no A1 sternite is observed, and in approximately half of the *F2^attP^* flies, the morphology of the A1 tergite is similar to wild type. In the remaining flies, the tergite is slightly deformed (see [Fig. 6](#F6){ref-type="fig"}). In embryos, a few speckles of Abd-A expression can be detected in PS6, suggesting that *F2*^*177*Δ*41*^ does not completely block *bxd*/*iab-2* cross-talk at this stage of development ([Fig. 6](#F6){ref-type="fig"}). Similar to *F2^attP^*, all *F2*^*177*Δ*41*^ homozygotes displayed a crumpled wing phenotype. Because the dCTCF-binding site is not so critical for the blocking activity of *F2^177^*, we tested the smaller *F2^95^* sequence in *F2^attP^*. As was the case when this truncated element was used as a *Fab-7* replacement, the presence of the Su(Hw)-binding site in *F2^95^* is not sufficient for boundary function ([Fig. 6](#F6){ref-type="fig"}). In *F2^95^* flies, A1 is completely transformed into A2, and we also observe a strong wing phenotype. However, unlike homozygous *F2^attP^* flies, homozygous *F2^95^* flies have normal viability. These results indicate that besides Su(Hw), additional unknown architectural proteins are required for the boundary activity of the *F2^177^* fragment.

As *CTCF^×4^* and *M^340^* were able to block cross-talk between *iab-6* and *iab-7* when inserted in place of *Fab-7*, we tested whether they could insulate *bxd* from *iab-2* when inserted in *F2^attP^*. For *CTCF^×4^*, we found that it has insulating activity in this context, although this activity is not complete. On the dorsal side, patches of tissue in the A1 tergite have an A2-like morphology, while on the ventral side, a partially developed sternite is typically observed. On the other hand, flies carrying the *M^340^* replacement are indistinguishable from wild-type flies. At the same time, both *CTCF^×4^* and *M^340^* completely restore boundary activity in *F2^attP^* embryos ([Fig. 6](#F6){ref-type="fig"} and figs. S6 and S7).

DISCUSSION
==========

In mammals, insulator activity has been ascribed to the polydactyl C2H2 zinc finger DNA binding protein, CTCF ([@R3]). A substantial portion of the TADs in mammals is bracketed by single convergently oriented binding sites for CTCF, and this observation has suggested that single CTCF-binding sites are sufficient to generate a fully functional chromatin boundary ([@R1]). Although this model is consistent with available genome-wide data in mammals, there have been few, if any, attempts to directly demonstrate sufficiency.

To address the questions of necessity and sufficiency, we used two boundary replacement platforms, *Fab-7* and *Fub*, in the *Drosophila* BX-C. In both platforms, the endogenous boundary was deleted and replaced with an *attP* site, which can be used to introduce sequences of interest. Like boundary deletions elsewhere within the BX-C, the *Fab-7* and *Fub* deletions fuse neighboring regulatory domains ([@R22], [@R26]). In the *Fab-7* deletion, the fused *iab-6* and *iab-7* domains misregulated *Abd-B* expression in PS11/A6, whereas in the *Fub* deletion, the fused *bxd* and *iab-2* domains misregulated *abd-A* expression in PS6/A1. In both cases, the misexpression of homeotic genes induces readily identifiable alterations in segmental morphology, providing a very sensitive assay for boundary function.

Although the regulatory consequences of deleting the *Fab-7* and *Fub* boundaries were similar, with neighboring regulatory domains fusing to induce predominantly GOF transformations in parasegment/segment identities, these two boundaries function at different levels of chromosome organization. In tissue culture--based Hi-C experiments, *Fub* marks the boundary between two large TADs, one that encompasses the *Ubx* gene and its two regulatory domains and one that encompasses the *abd-A* gene and its three regulatory domains ([@R33]). The *Fab-7* boundary, in contrast, is located within a large TAD that includes the four *Abd-B* regulatory domains, *iab-5*, *iab-6*, *iab-7*, and *iab-8*, plus the *Abd-B* gene and its various upstream promoters. Thus, the *Fab-7* boundary defines a "sub-TAD" level of chromosomal organization, and similar to the other boundaries within the larger *Abd-B* TAD, it has both insulating and bypass activities.

We tested sequences derived from three endogenous BX-C boundaries, *Fab-8*, *Mcp*, and *Fub*, for their insulating activity using these two platforms ([Fig. 1](#F1){ref-type="fig"}). Like boundaries in the mammalian Hox complexes ([@R34]--[@R36]), all three boundaries contain binding sites for the dCTCF protein. *Fab-8* has two binding sites, while there is one in *Mcp* and *Fub*. *Mcp* and *Fub* have binding sites for at least one other polydactyl zinc finger DNA binding protein: Pita in *Mcp*, and Su(Hw) in *Fub*. Previous studies have shown that the two dCTCF-binding sites in *Fab-8* are essential for insulating activity, as are the sites for Pita and dCTCF in *Mcp* ([@R12], [@R18], [@R20]). However, as we show here, these binding sites alone are not sufficient for boundary function. Although a 209-bp *Fab-8* sequence that contains both dCTCF sites is able to block cross-talk between *iab-6* and *iab-7*, a smaller 106-bp truncation has no insulating activity, even though both dCTCF-binding sites are present. A similar result was obtained for the Pita and dCTCF combination in *Mcp*. Although the full-length 340-bp *Mcp* sequence has full boundary function, a 65-bp sequence spanning the Pita and dCTCF sites has no detectable activity.

One reason why the shorter *Fab-8* and *Mcp* sequences lack insulator activity is that dCTCF binding is reduced. These findings indicate that dCTCF requires the assistance of accessory DNA binding factors to bind to its recognition sequence in chromatin. For *Fab-8*, these accessory factors would presumably interact with sequences distal to the two dCTCF-binding sites. Although the identities of the factors in *Fab-8* that promote dCTCF binding remain unknown, previous studies have suggested that Pita may play this role in *Mcp* ([@R20]). When we mutated the Pita site in *M^340^*, we found that dCTCF binding was reduced by more than fivefold compared with wild-type boundary. However, Pita is likely not the only factor that facilitates dCTCF binding to *Mcp*. Whereas Pita association with the truncated *M^65^* replacement is similar to that observed for *M^340^*, dCTCF binding is still reduced more than threefold. These findings indicate that the fly dCTCF is unable to bind to a single site in chromatin without the assistance of other factors. In this respect, the fly protein must differ from the mammalian CTCF, which is believed to function like a pioneer protein and be able to bind to single cognate recognition sequence without the assistance of other accessory DNA binding proteins.

This is not the only difference between the fly and mammalian CTCF proteins. According to the loop extrusion model, single (convergent) CTCF-binding sites are sufficient to generate a boundary element that is capable of subdividing the chromosome into functionally autonomous domains, insulating the genes and regulatory elements on one side of the boundary from the genes and regulatory elements on the other side of the boundary ([@R4], [@R35], [@R37]). By contrast, single dCTCF sites are not sufficient for boundary function in flies at least in the context of BX-C. In *Fab-7* replacements, four copies of the CTCF-binding site are required for boundary function, whereas three copies have no insulating activity. While dCTCF binding to *CTCF^×3^* is less than that observed for the *CTCF^×4^* element, this is probably not the only factor contributing to the difference in boundary function. In particular, the insulating activity of *CTCF^×3^* can be substantially enhanced by combining it with one of the *Fab-7* LBC elements, *HS3*; however, despite this increased functionality, there is little, if any, change in the level of dCTCF association. A similar result was observed for the defective *F8^106^* element: dCTCF association remained low in the *F8^106^ + HS3* combination, even though insulating activity was significantly enhanced. These observations suggest that, although single sites for dCTCF might be necessary for insulating activity, they are not in themselves sufficient. Instead, multiple dCTCF-binding sites or other factors such as Pita or the LBC must be deployed to generate an element that can function as an insulator.

In addition, we found that the dCTCF association was not always necessary for insulating activity. For the *Fub* boundary sequence *F2^177^*, the deletion of either just the dCTCF site or a 41-bp sequence spanning the dCTCF site had no apparent effects on its ability to block cross-talk between *iab-6* and *iab-7* when inserted in the place of *Fab-7*. The dCTCF site also appears to be largely dispensable for the insulating activity of *F2^177^* in its native location, between the *bxd* and *iab-2* regulatory domains. Although the blocking activity of *F2*^*177*Δ*41*^ was not fully equivalent to that of *F2^177^*, flies carrying the 41-bp deletion were nearly indistinguishable from wild-type flies. In contrast, mutation of the single Su(Hw)-binding sequence disrupted the insulating activity of *F2^177^* in both the *Fab-7* and *Fub* replacements. In these two BX-C replacement contexts, the phenotype of the *F2*^*177*Δ*Su*^ mutant was essentially indistinguishable from the initial *attP* deletions. Moreover, as was observed for the Pita mutations in *Mcp*, mutating the Su(Hw)-binding site in *F2*^*177*Δ*Su*^ reduced dCTCF binding.

Although the association of Pita and Su(Hw) with their binding sites in the *Mcp* and *Fub* boundaries was not greatly affected by mutations in the dCTCF sites, whether either of these proteins would be able to access their respective single cognate binding sites without the help of accessory DNA binding proteins remains unclear. However, single Pita- or Su(Hw)-binding sites alone are not sufficient to generate insulator activity. In previous studies on the *Fab-7* boundary, we found that the two Pita sites in HS2 were unable to confer boundary activity, even in the presence of HS3 ([@R27]). Moreover, they are also unnecessary, as a fully functional *Fab-7* boundary can be reconstituted from other *Fab-7* sequences, without including the Pita sites in HS2 ([@R16]). In the case of Su(Hw), enhancer-blocking transgene experiments showed that similar to dCTCF, three copies of the Su(Hw)-binding site resulted in little, if any, insulator activity, whereas four copies were sufficient to block enhancer-promoter interactions ([@R38]).

The experiments described above demonstrate that single recognition sequences for fly polydactyl C2H2 zinc finger DNA binding proteins, such as dCTCF, are insufficient to confer insulator functionality. Although these results indicate that popular models for the assembly and functioning of insulators in vertebrates are unlikely to be applicable in flies, it is not clear to what extent our findings are relevant in vertebrates as the DNA binding and insulator activities of vertebrate CTCF sites and the cognate CTCF protein remain largely unexplored. Consistent with the idea that the insulators at TAD boundaries in vertebrates are generated by a pair of single convergent CTCF-binding sites, mutations in CTCF sites at TAD borders or the deletions of these sites plus their surrounding sequences have been found to disrupt boundary function and/or change the patterns of gene regulation ([@R6], [@R35]--[@R37], [@R39]). However, the correlation between convergently oriented CTCF sites and insulator formation may only tell part of the story. A substantial fraction of the TADs in murine stem cells are not delimited by convergent CTCF sites ([@R6]), and in several cases, mutations in single or even multiple CTCF sites have no apparent impact on boundary functions or regulatory interactions ([@R6], [@R40]). In addition, there are thousands of CTCF sites in vertebrate chromosomes that do not correspond to TAD boundaries, and the factors that distinguish these sites from sites that are thought to delimit TADs remain unknown ([@R4]). Last, as we have found here, sufficiency and necessity are not always equivalent.

MATERIALS AND METHODS
=====================

Chromatin immunoprecipitation
-----------------------------

Chromatin for the immunoprecipitations was prepared from 3-day-old adult flies as described in ([@R12]). Aliquots of chromatin were incubated with rabbit antibodies against Pita (1:500) ([@R12]), Su(Hw) (1:1000), dCTCF (1:500), and CP190 (1:500) ([@R12]) or with nonspecific rabbit immunoglobulin G (control). At least two independent biological replicates were made for each chromatin sample. The results of the ChIP experiments are presented as a percentage of the input genomic DNA after triplicate polymerase chain reaction (PCR) measurements. The *RpL32* coding region (devoid of binding sites for the test proteins) was used as negative control; 59F5, 100C, and 62D regions were used as positive controls.

Electrophoretic mobility shift assay
------------------------------------

Recombinant proteins for the binding assays were expressed and purified as described in ([@R12]). Fluorescently labeled DNA fragments were generated by PCR amplification with the corresponding fluorescein amidite (FAM)-- or Cy5-labeled primers. Aliquots of purified recombinant proteins (10 to 15 μg) were incubated with the fluorescently labeled DNA fragments in the presence of nonspecific binding competitor poly(dI dC). Incubations were performed in phosphate-buffered saline (pH 8.0) containing 5 mM MgCl~2~, 0.1 mM ZnSO~4~, 1 mM dithiothreitol, 0.1% NP-40, and 10% glycerol at room temperature for 30 min. The mixtures were resolved by nondenaturing 5% polyacrylamide gel electrophoresis in 0.5× TBE (tris-borate EDTA) buffer at 5 V/cm. Signals were detected using the Kodak Image System for the FAM-labeled fragments at excitation (Ex) 500 nm/emission (Em) 535 nm and for the Cy5-labeled fragments at the Ex 630 nm/Em 700 nm.

Generation of *F2^attP^* by CRISPR-*Cas9*--induced homologous recombination
---------------------------------------------------------------------------

For generating double-stranded DNA donors for homology-directed repair, we used *pHD-DsRed* vector that was a gift from K. O\'Connor-Giles (Addgene plasmid no. 51434). The final plasmid contains genetic elements in the following order: \[*bxd* proximal arm\]-\[*attP*\]-\[*lox*\]-\[*3×P3-dsRed-SV40polyA*\]-\[*lox*\]-\[*iab-2* distal arm\]. Homology arms were PCR amplified from *yw* genomic DNA using the following primers: ATA*GCGGCCGC*CGTTGAATGAATCCCC and ATA*CATATG*CTTGGCTTGATCTTGGCAG for the proximal arm (995-bp fragment), and ATA*AGATCT*GGGGCAAAGTTTTGATTG and ATA*CTCGAG*CGTTGCGGTTTCGGATTAC for the distal arm (914-bp fragment). Targets for *Cas9* were selected using "CRISPR optimal target finder"---the program from O\'Connor-Giles Laboratory. The recombination plasmid was injected into embryos of *y\[1\] M\[Act5C-Cas9.P.RFP-\]ZH-2A w\[1118\] DNAlig4\[169\]* (58492 from the Bloomington Drosophila Stock Center) together with two single-guide RNAs containing the following guides: GATTTGTAATGAAACTGTTC and GATTTCGGACTAATGTTGCT. Injectees were grown to adulthood and crossed with *y w*; *TM6/MKRS* line. Flies with dsRed-signal in eyes and the abdomens were selected into a new separate line. The successful integration of the recombination plasmid was verified by PCR and corresponds to the removal of 2106 bp within the *Fub* region (genome release R6.22: 3R:16,797,757..16,799,862; or complete sequence of BX-C in SEQ89E numbering: 183,576 to 185,681).

Generation of the replacement lines
-----------------------------------

The strategy of the *Fab-7* replacement lines is described in detail in ([@R27]). For the *F2^attP^* replacement, the recombination plasmid was designed de novo and contains several genetic elements in the following order: \[*attB*\]-\[*pl*\]-\[*lox*\]-\[*3P3-mCherry*\]-\[*mini-y*\] (fig. S5). All elements were assembled within the *pBluescript SK* vector. *loxP* site is located after *polylinker* \[*pl*\] and in combination with the second site, which is located in the platform, use for excision of marker genes and plasmid body. DNA fragments used for the replacement experiments were generated by PCR amplification and verified by sequencing (presented in the Supplementary Methods).

Cuticle preparations
--------------------

Adult abdominal cuticles of homozygous enclosed 3-day-old flies were prepared essentially as described in ([@R28]). Photographs in the bright or dark field were taken on the Nikon SMZ18 stereomicroscope using a Nikon DS-Ri2 digital camera, processed with ImageJ 1.50c4 and Fiji bundle 2.0.0-rc-46.

Embryo immunostaining
---------------------

Primary antibodies were mouse monoclonal anti-Ubx at 1:30 dilution (FP3.38, generated by R. White, deposited to the Developmental Studies Hybridoma Bank), anti--abd-A at 1:50 dilution (sc-390990, purchased from Santa Cruz Biotechnology), and polyclonal rabbit anti-engrailed at 1:2000 dilution (a gift from J. Kassis). Secondary antibodies were goat anti-mouse Alexa Fluor 546 and anti-rabbit Alexa Fluor 488 (Thermo Fisher Scientific) at 1:500 dilution. Stained embryos were mounted in the following solution: 23% glycerol, 10% Mowiol 4-88, 0.1 M tris-HCl (pH 8.3). Images were acquired on a Nikon A1 HD25 confocal microscope and processed using ImageJ 1.50c4.
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Supplementary Methods

Fig. S1. Morphology of the abdominal segments (numbered) in males carrying different variants of the *Fab-8* or CTCF site replacements in Fab-*7^attP50^* in the dark field.

Fig. S2. Morphology of the abdominal segments (numbered) in males carrying different variants of *Mcp* in *Fab-7^attP50^* in the dark field.

Fig. S3. Morphology of the abdominal segments (numbered) in males carrying different variants of *F2^177^* in *Fab-7^attP50^* in the dark field.

Fig. S4. In vitro binding of dCTCF and Su(Hw) to *F2^177^*and its derivatives.

Fig. S5. Strategy for creating *Fub* replacement lines.

Fig. S6. A lateral view of abd-A expression patterns in stage 14 embryos carrying different substitutions in *F2^attP^*.

Fig. S7. *Ubx* expression in *F2^attP^*, *F2177*, and *F2177DC*, exhibiting wing phenotypes.

[View/request a protocol for this paper from *Bio-protocol*](https://en.bio-protocol.org/cjrap.aspx?eid=10.1126/sciadv.aaz3152).
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